Delivery Order SPE2DB22D3501-SPE2DB25FUE18

Award Date 1/16/25
Potential Completion Date 1/17/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,156.39 firm fixed-price delivery order is for the supply of ZORYVE 0.3% CREAM 60GM, a pharmaceutical product. The contract has an ultimate completion date of October 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
This federal contract award, valued at $1,113.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,345.15 firm fixed-price contract is for the supply of the medication "ZORYVE 0.3% CREAM 60GM" and has an ultimate completion date of December 5, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, with ID SPE2DB22D3301|SPE2DB25FX5JN, was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZORYVE 0.3% CREAM 60GM, a medical product, with a ceiling value of $6,712.54 and a completion date of November 13, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, with ID SPE2DB25D3504|SPE2DB25FVTYL, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,133.72 firm fixed price delivery order is for the supply of ZORYVE 0.3% cream, a pharmaceutical product. The contract has an ultimate completion date of March 26, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, with an ID of SPE2DB22D3501|SPE2DB25FTX53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,799.19 delivery order is for the supply of ZORYVE 0.3% CREAM 60GM, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of December 24, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,781.33 firm fixed-price delivery order is for the supply of 4567585489 ! ZORYVE 0.3% FOAM 60GM medical products, with a period of performance through March 17, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,384.83, is for the supply of the pharmaceutical product ZORYVE 0.3% FOAM 60GM. The contract has a firm fixed price pricing type and a period of performance through February 7, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,310.30 delivery order contract is for the provision of ZORYVE 0.3% FOAM 60GM, a medical product, with a performance period through April 2025. The contract is not set aside and is considered an open competition award. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This federal contract award, valued at $2,988.77, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZORYVE 0.3% FOAM 60GM, a topical medication, and does not have a set-aside designation. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FUE18
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,391.11 firm-fixed-price delivery order is for the supply of ZORYVE 0.3% cream, a prescription medication. The contract has an ultimate completion date of January 17, 2025.

Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

The contract award reviewed was not designated with any set-aside requirements, indicating open competition.

Generated 5/21/25, 10:21 AM